Retatrutide has emerged as a new medication in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By activating these https://kaitlynyvrd835885.mybloglicious.com/56290265/setmelanotide-a-promising-new-treatment-for-obesity